Chong Kun Dang Corp. · 66-66 · KOREA (THE REPUBLIC OF)

For Chong Kun Dang Corp. · 66-66 · KOREA (THE REPUBLIC OF), import alert is 66-66; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; country is KOREA (THE REPUBLIC OF); product is Demeclocyclene | Lovastatin | Lovastatin; product code is 56 E - S 15 Demecloclycline Hydrochloride (Tetracyclines), Active Pharm Ingred/Chems for Further Manuf | 61 J - S 12 Lovastatin (Anti-Cholesteremic), Active Pharm Ingred/Chems for Further Manuf | 62 B - S 99 Anti-Hyperlipidemic N.E.C., Active Pharm Ingred/Chems for Further Manuf; date published is 09/30/2009; address is 410, Sintorim-Dong, Yong Dungpo-Ku , Seoul, KOREA (THE REPUBLIC OF), verified against its source on 2026-09-16.

What the source says

Chong Kun Dang Corp. Date Published : 09/30/2009 410, Sintorim-Dong, Yong Dungpo-Ku , Seoul, KOREA (THE REPUBLIC OF) 56 E - S 15 Demecloclycline Hydrochloride (Tetracyclines), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/21/2019 Desc: Demeclocyclene Notes: 11/2/2000 61 J - S 12 Lovastatin (Anti-Cholesteremic), Active Pharm Ingred/Chems for Further Manuf Date Published: 03/21/2019 Desc: Lovastatin Notes: 11/2/2000 62 B - S 99 Anti-Hyperlipidemic N.E.C., Active Pharm Ingred/Chems for Further Manuf Date Published: 03/21/2019 Desc: Lovastatin Notes: 11/2/2000

— accessdata.fda.gov, retrieved 2026-09-15

Source

• accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified against source: 2026-09-16. Due for re-check by 2026-11-15. This page as Markdown · OKF bundle · full dataset as JSON.